Xtant Medical PE ratio XTNT

Share price divided by earnings per share over the last twelve months, since 2023.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 44.4×; Aug 2026
3-year median: 62.1×
3-year range: 16.0× to 130×
Peer median: 15.1×

Xtant Medical has no meaningful PE ratio today: it lost $0.08 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Aug 2026, at 44.4×.

On the days it had one over the last 3 years, its median was 62.1×, from 16.0× in Apr 2026 to 130× in Dec 2023.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	44.4×	16.0×	74.7×
2025	77.6×	59.0×	77.6×
2024	117×	103×	119×
2023	113×	110×	130×

Against its peers

Companies in Medical - Instruments & Supplies nearest Xtant Medical's size, closest first, today.

Company	PE ratio
XTNTXtant Medical	n/m
NEPHNephros	22.1×
APTAlpha Pro Tech	13.6×
KEQUKewaunee Scientific	11.9×
PDEXPro DEX	15.1×
UTMDUtah Medical Products	22.6×
INFUInfuSystem	34.0×
EMBCEmbecta	4.6×
Peer median	15.1×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Xtant Medical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.